We are live on ! Find out more

Stocks Most Commonly
Held By Funds

Funds Holding Holding in Top 10 New Positions Closed Positions Increased Positions Reduced Positions Call Options Put Options
Name Funds
holding 		Growth Growth % Return since
31 Mar ‘20
CRVS icon
601
Corvus Pharmaceuticals
CRVS
$1.24B
43 +6 +16% 598%
AVTX icon
602
Avalo Therapeutics
AVTX
$1.1B
43 +6 +16% 99.7%
PINE
603
Alpine Income Property Trust
PINE
$347M
36 +5 +16% 60%
RCEL icon
604
Avita Medical
RCEL
$328M
36 +5 +16% 65.8%
REGN icon
605
Regeneron Pharmaceuticals
REGN
$83.9B
816 +113 +16% 66.9%
CGEN icon
606
Compugen
CGEN
$269M
65 +9 +16% 60.9%
SILJ icon
607
Amplify Junior Silver Miners ETF
SILJ
$4.28B
29 +4 +16% 386%
EDV icon
608
Vanguard World Funds Extended Duration ETF
EDV
$3.55B
109 +15 +16% 63.6%
GOF icon
609
Guggenheim Strategic Opportunities Fund
GOF
$2.17B
66 +9 +16% 36.5%
GAA icon
610
Cambria Global Asset Allocation ETF
GAA
$75.8M
22 +3 +16% 59.9%
PTH icon
611
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$276M
59 +8 +16% 124%
GCMG icon
612
GCM Grosvenor
GCMG
$829M
37 +5 +16% 31.8%
OPP
613
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$186M
52 +7 +16% 41%
XCUR icon
614
Exicure
XCUR
$8.25M
52 +7 +16% 99.4%
JMST icon
615
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.26B
67 +9 +16% 1.05%
ETJ
616
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$568M
82 +11 +15% 1.44%
SPTI icon
617
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.7B
127 +17 +15% 15%
FAAR icon
618
First Trust Alternative Absolute Return Strategy ETF
FAAR
$204M
30 +4 +15% 22%
CREX icon
619
Creative Realities
CREX
$38.6M
15 +2 +15% 21.3%
JRSH icon
620
Jerash Holdings
JRSH
$71.5M
15 +2 +15% 10.6%
SNDX icon
621
Syndax Pharmaceuticals
SNDX
$1.79B
83 +11 +15% 83.1%
COLL icon
622
Collegium Pharmaceutical
COLL
$853M
159 +21 +15% 68.5%
INSW icon
623
International Seaways
INSW
$4.64B
130 +17 +15% 292%
VPV icon
624
Invesco Pennsylvania Value Municipal Income Trust
VPV
$203M
46 +6 +15% 6.43%
JOF
625
Japan Smaller Capitalization Fund
JOF
$355M
46 +6 +15% 77.7%
23 24
25
26 27